Skyrizi 600 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
7680689470016
CH-68947
Konzentrat
Associated product:
SKYRIZI conc perf 600 mg/10ml flac 10 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
600.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.09 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2343.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2023
Authorization holder
AbbVie AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 68947
- Drug name
- Skyrizi, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AC18
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 14/09/2023
- Authorization expiration date
- 13/09/2028
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- SKYRIZI conc perf 600 mg/10ml flac 10 ml
- Description (DE)
- SKYRIZI Inf Konz 600 mg/10ml Durchstf 10 ml
- Market launch
- 14/09/2023
- Narcotic (BTM)
- No
Other package sizes (1)
SKYRIZI 600 mg/10 ml conc perf 600 mg 2 pce
2 DUR
GTIN: 7680689470023